AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Akeso
- Target Recruit Count
- 233
- Registration Number
- NCT05904379
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
🇨🇳Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
- Conditions
- Interventions
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Akeso
- Target Recruit Count
- 205
- Registration Number
- NCT05868876
- Locations
- 🇨🇳
Tianjin Cancer Hospital, Tianjin, Tianjin, China
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Akeso
- Target Recruit Count
- 78
- Registration Number
- NCT05859750
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Union Hospital Tongji Medical College Huazhong University of Science And Technology, Wuhan, Hubei, China
Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Akeso
- Target Recruit Count
- 72
- Registration Number
- NCT05846867
- Locations
- 🇨🇳
Cancer Hospital Affiliated to Harbin Medical University, Harbin, China
AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Akeso
- Target Recruit Count
- 396
- Registration Number
- NCT05840016
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- Akeso
- Target Recruit Count
- 87
- Registration Number
- NCT05689853
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
A Study of AK130 in Patients With Advanced Malignant Tumors
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Akeso
- Target Recruit Count
- 19
- Registration Number
- NCT05653284
- Locations
- 🇨🇳
The Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
A Study of AK129 in Patients With Advanced Malignant Tumors
- Conditions
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Akeso
- Target Recruit Count
- 182
- Registration Number
- NCT05645276
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
- Conditions
- Interventions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Akeso
- Target Recruit Count
- 114
- Registration Number
- NCT05636267
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, China
Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-09-29
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Akeso
- Target Recruit Count
- 102
- Registration Number
- NCT05559541
- Locations
- 🇨🇳
Tianjin Medical University Cancer Insitute & Hospital, Tianjin, Tianjin, China